Endoplasmic reticulum (ER) News and Research

RSS

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

Mississauga Halton LHIN's SDL program receives 3M National Award for Health Care Quality

The Mississauga Halton Local Health Integration Network (LHIN) is proud to announce that it is the single systems-level recipient of the prestigious 3M National Award for Health Care Quality at the National Conference of Canadian Health Care Leaders, on June 7th 2011.

23 Jun 2011

New insight into progressive supranuclear palsy

There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a new study from an international genetics team led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

20 Jun 2011

Two thirds of women with breast cancer more likely to die from cardiovascular disease

Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease.

20 Jun 2011

Prior GID diagnosis impacts health outcomes of patients with Parkinson's

A new study investigating the incidence and impact of gastrointestinal disorders (GID) among patients with Parkinson's disease (PD) found that patients who received both a PD diagnosis and a prior GID diagnosis appeared to have worse health outcomes compared to patients who received a diagnosis for PD with no prior GID diagnosis.

16 Jun 2011

FDA clears Mitsubishi's PATHFAST cardiac Troponin I diagnostic test

Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST cTnI-II diagnostic test, clearing the way for its sale in the United States.

14 Jun 2011

Oncogene Aurora A may contribute to polycystic kidney disease

The Aurora A kinase may contribute to polycystic kidney disease (PKD) by inactivating a key calcium channel in kidney cells, according to a study in the June 13 issue of The Journal of Cell Biology.

13 Jun 2011

Researchers unearth secret of immune system's success

After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success. The findings published online on June 9th in Immunity, a Cell Press publication, offer an explanation for how specialized immune cells are able to kill infected or cancerous cells without killing themselves in the process.

From Evident Corporation - Life Sciences 10 Jun 2011

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.

8 Jun 2011

State roundup: Texas legislator seeks to force vote on 'health care compact'

Two Atlanta gatherings Monday showed that health care isn't waiting around for whatever happens to the 2010 reform law. Gov. Nathan Deal's committee on health exchanges met at the state Capitol for introductions and background on their task. ... Ryan Teague, deputy executive counsel for the governor, said the health reform law is "a heavyhanded approach to expanding Medicaid."

8 Jun 2011

AMPYRA ER Tablets improve walking ability in patients with multiple sclerosis

Acorda Therapeutics, Inc. today announced an analysis of pooled clinical trial results showed patients who were responders to AMPYRA (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.

7 Jun 2011

Actavis receives final FDA approval for Zolpidem ER Tablets

Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced.

7 Jun 2011

GTx to initiate two Ostarine Phase III trial for treatment of muscle wasting in patients with NSCLC

Following the conclusion of a series of meetings with the United States Food and Drug Administration (FDA), GTx, Inc. announced today the clinical trial design for the two Phase III Ostarine registration studies for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer (NSCLC).

6 Jun 2011

News highlights: Study finds reform didn't slow ER visits in Mass.; 2 ACOs take shape in Calif.; Md. hospitals report problems

Health care reform in Massachusetts only had a small impact on the number of trips residents took to the emergency room, according to a new study.

4 Jun 2011

CICC White Paper identifies several care gaps of atrial fibrillation patients in Ontario

A White Paper released today by the Centre for Innovation in Complex Care (CICC), of the University Health Network (UHN), has identified significant care gaps of atrial fibrillation (AF) patients in Ontario, which contribute to debilitating strokes that could be prevented.

3 Jun 2011

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.

3 Jun 2011

New smart phone application provides pediatric and adult ER wait times directly to phone

Managing your health just got easier with the launch of Emergency Room (ER) wait times for adult and pediatric HealthONE ERs throughout the Denver metro area. The new Denver smart phone application, HealthONE Fast LocatER, will provide wait times directly to your smart phone as well as locate the nearest HealthONE ER, find a physician, make an appointment request, call 911 and more.

27 May 2011

SEIU-UHW members at Tenet Hospitals reach tentative agreement to maintain high quality patient care

Certified nurse assistants, respiratory therapists, ER technicians and other caregivers who are members of Service Employees International Union, United Healthcare Workers - West at Tenet Hospitals have reached a tentative agreement that will help the hospitals maintain high standards for patient care.

27 May 2011

Tigris Pharmaceuticals begins enrollment in AFP-464 Phase 2 trial in ER-positive breast cancer

Tigris Pharmaceuticals, Inc., today announced enrollment of its first patient in a randomized Phase 2 clinical trial of AFP-464 with or without Faslodex in estrogen receptor (ER)-positive breast cancer patients.

27 May 2011

Ocean County, Conmed sign new agreement to provide correctional healthcare services for detainees

Conmed Healthcare Management, Inc. has signed a new agreement with Ocean County, New Jersey, to provide correctional healthcare services for the detainees at its jail for an initial three-year term, beginning July 1, 2011, with two optional one-year renewals.

24 May 2011

Endoplasmic reticulum (ER) News and Research

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Mississauga Halton LHIN's SDL program receives 3M National Award for Health Care Quality

New insight into progressive supranuclear palsy

Two thirds of women with breast cancer more likely to die from cardiovascular disease

Prior GID diagnosis impacts health outcomes of patients with Parkinson's

FDA clears Mitsubishi's PATHFAST cardiac Troponin I diagnostic test

Oncogene Aurora A may contribute to polycystic kidney disease

Researchers unearth secret of immune system's success

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

State roundup: Texas legislator seeks to force vote on 'health care compact'

AMPYRA ER Tablets improve walking ability in patients with multiple sclerosis

Actavis receives final FDA approval for Zolpidem ER Tablets

GTx to initiate two Ostarine Phase III trial for treatment of muscle wasting in patients with NSCLC

News highlights: Study finds reform didn't slow ER visits in Mass.; 2 ACOs take shape in Calif.; Md. hospitals report problems

CICC White Paper identifies several care gaps of atrial fibrillation patients in Ontario

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

New smart phone application provides pediatric and adult ER wait times directly to phone

SEIU-UHW members at Tenet Hospitals reach tentative agreement to maintain high quality patient care

Tigris Pharmaceuticals begins enrollment in AFP-464 Phase 2 trial in ER-positive breast cancer

Ocean County, Conmed sign new agreement to provide correctional healthcare services for detainees

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News